Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Prostaglandin D2 expression is prognostic in high‑grade serous ovarian cancer.

Alves MR, Do Amaral NS, Marchi FA, Silva FIB, Da Costa AABA, Carvalho KC, Baiocchi G, Soares FA, De Brot L, Rocha RM.

Oncol Rep. 2019 Apr;41(4):2254-2264. doi: 10.3892/or.2019.6984. Epub 2019 Jan 28.

PMID:
30720106
2.

Downregulation of AGR2, p21, and cyclin D and alterations in p53 function were associated with tumor progression and chemotherapy resistance in epithelial ovarian carcinoma.

Alves MR, E Melo NC, Barros-Filho MC, do Amaral NS, Silva FIB, Baiocchi Neto G, Soares FA, de Brot Andrade L, Rocha RM.

Cancer Med. 2018 May 29. doi: 10.1002/cam4.1530. [Epub ahead of print]

3.

Prognostic value of GRIM-19, NF-κB and IKK2 in patients with high-grade serous ovarian cancer.

Ilelis F, do Amaral NS, Alves MR, da Costa AABA, Calsavara VF, Lordello L, De Brot L, Soares FA, Rodrigues IS, Rocha RM.

Pathol Res Pract. 2018 Feb;214(2):187-194. doi: 10.1016/j.prp.2017.12.002. Epub 2017 Dec 6.

PMID:
29254797
4.

Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections.

Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, Ciccone M, Kargin OA, Zhang X, Mur P, do Amaral NS, Chen M, Tarrand JJ, Lupu F, Ferrajoli A, Keating MJ, Vasilescu C, Yeung SJ, Calin GA.

EBioMedicine. 2017 Jun;20:182-192. doi: 10.1016/j.ebiom.2017.04.018. Epub 2017 Apr 19.

5.

Noncoding RNA Profiles in Tobacco- and Alcohol-Associated Diseases.

Soares do Amaral N, Cruz E Melo N, de Melo Maia B, Malagoli Rocha R.

Genes (Basel). 2016 Dec 23;8(1). pii: E6. doi: 10.3390/genes8010006. Review.

6.

Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapy.

Kim J, de Sampaio PC, Lundy DM, Peng Q, Evans KW, Sugimoto H, Gagea M, Kienast Y, Amaral NSD, Rocha RM, Eikesdal HP, Lønning PE, Meric-Bernstam F, LeBleu VS.

JCI Insight. 2016 Dec 22;1(21):e90733. doi: 10.1172/jci.insight.90733.

7.

MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression.

de Melo Maia B, Rodrigues IS, Akagi EM, Soares do Amaral N, Ling H, Monroig P, Soares FA, Calin GA, Rocha RM.

Oncotarget. 2016 Aug 2;7(31):49217-49231. doi: 10.18632/oncotarget.10247.

Supplemental Content

Loading ...
Support Center